We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Proteomics aids drug re-purposing

News   Oct 12, 2017 | Original Story from Moffit Cancer Center

 
Proteomics aids drug re-purposing
 
 
Advertisement
 

RELATED ARTICLES

A Next-Generation Anti-Amyloid Vaccine for Alzheimer’s Disease?

News

A team led by Chuanhai Cao, PhD, of the University of South Florida Health (USF Health), has focused on overcoming, in those with impaired immunity, excess inflammation and other complications that interfere with development of a therapeutic Alzheimer’s vaccine.

READ MORE

Uncovering a Novel Mechanism for Disposing of Misfolded Proteins

News

About 30 years ago, Dr. Richard Sifers set out on a journey to discover why people with a rare condition known as alpha1-antitrypsin (AAT) deficiency present with high variation in the severity of liver disease. His journey led him to the discovery of fundamental underpinnings of this condition and, unexpectedly, to uncovering a novel cellular mechanism for disposing of misfolded proteins.

READ MORE

Neuropilin-1 Identified as a Facilitator for SARS-CoV-2 Entry Into Cells’ Interior

News

The coronavirus SARS-CoV-2 is known to infect cells via the receptor ACE2. An international research team under German-Finnish coordination has now identified neuropilin-1 as a factor that can facilitate SARS-CoV-2 entry into the cells’ interior.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE